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Drug Action- The Therapeutic Effect
Abstract
In this article in the series of ‘bite sized’ pharmacology, we will look at the concept of drug 
action- the therapeutic effect of the medications we give. It is important that prescribers are 
aware of factors that can affect drug action and the time to onset of and subsequent duration 
of the desired therapeutic effect. We will look at factors that affect these two important areas 
of drug action.  Knowledge of these factors can assist the prescriber when deciding on doses 
and dose schedules to ensure that patients receive their medications at the correct dosing, by 
the correct route and in the right formulation to ensure optimum therapeutic effect. It also 
helps the prescriber understand why dose adjustments are made or some drugs are avoided in 
patients with hepatic or renal impairment. 
Time to Onset
The time to the onset of drug action is the time taken form the point of drug administration 
until the drug is delivered to its site of action. This is controlled by three main factors;
 The route of administration of the drug
 The rate of absorption of the drug 
 The manner of distribution of the drug
We often want the drug we give to have its effect within a certain time frame. This is 
especially important in the cases of one off does of medication such as analgesia as it’s 
important to be able to monitor response and knowing when response is expected helps us 
assess our patients more accurately. 
We can affect the time to the onset of drug action in many ways. The first is the route of 
administration. If drug action is needed more quickly, we can use the IM or IV route as 
necessary. We can also delay drug onset by using transdermal or SC routes. Box 1 shows the 
main routes of drug administration and their advantages and disadvantages.
Box 1
ROUTE ADVANTAGES DISADVANTAGES
ENTERAL ROUTES 
ORAL Convenient, non-
sterile, good 
absorption for 
most drugs, 
medium onset of 
action
Gastrointestinal (GI) 
irritation, potential 
for interactions, first 
pass destruction, 
inactivated by acids, 
variable absorption 
SUBLINGUAL/BUCCAL Avoids first pass,
avoids gastric 
acid, fast acting
Few preparations 
suitable 
RECTAL Avoids first pass,
avoids gastric 
acid, medium 
onset of action
Less dignified for the
patient 
PARENTERAL (refers to IV, IM and SC) ROUTES 
INTRAVENOUS (IV) Rapid action, 
complete 
availability 
Increased drug levels
to heart, must be 
sterile, risk of sepsis 
and embolism 
INTRAMUSCULAR 
(IM) 
Rapid 
absorption, fact 
action
Painful, risk of tissue
damage 
SUBCUTANEOUS (SC) 
Good for slower 
absorption and 
where delayed 
onset may be 
advantageous 
Absorption variable 
INHALED (LUNGS) Large absorption
area, good for 
topical use, rapid
onset of action
Few disadvantages 
Adapted from Barber & Robertson (2015)
Exercise
Using pharmacologically available resources such as textbooks, the BNF or online electronic 
medicines compendium, find out the different routes of administration available for a drug 
from your area of practice. Use this information and your knowledge of patients you may 
prescribe for to reflect on what information you would need and how you would chose a 
route for a particular patient. 
After we have chosen the route of administration best suited to the drug and patient we can 
use our knowledge of the pharmacological processes of Absorption and Distribution to 
predict and affect time to onset.  
Absorption
The main factors that affect drug absorption that you may remember from our 
pharmacokinetics article are physiological and physicochemical. We will look at the oral 
route of administration as an example.
Physiological
Drug absorption by the oral route can be affected by the presence or absence of food in the 
stomach. Some drugs should be given on an empty stomach and therefore well before or after
food. This is to maximise their absorption. Some drugs should be given with food, this often 
starts peristalsis and moves the drug to the small intestine where the majority of its absorption
takes place. Drugs which are given orally that do not specify food timing can be absorbed 
well with or without food present.
Physicochemical
If the drug is given orally, we can use liquid or dispersible formulations instead of regular 
tablets. These are absorbed more quickly and readily form the gastrointestinal tract and can 
reduce the time to onset of drug action. We can also delay drug onset by using enteric coated 
or slow release preparations orally. 
Exercise
Using pharmacologically available resources such as textbooks, the BNF or online electronic 
medicines compendium, look at the different preparations available for a drug from your area 
of practice. Use this information and your knowledge of patients you may prescribe for to 
reflect on what information you would need and how you would chose a preparation for a 
particular patient.
Distribution
The main factor that affect drug distribution that you may remember from our 
pharmacokinetics article is plasma protein binding.
Plasma Protein Binding
When a drug is absorbed and enters the plasma it will be subjected to binding to plasma 
proteins. Any drug bound to a plasma protein is pharmacologically inert, only the drug that is 
‘free’ in the plasma can go on to its target site and have activity. The degree of binding is 
controlled by the amount of drug that has reached the systemic circulation (bioavailability), 
what affinity that drug has for the biding sites on the proteins, and the amount of plasma 
proteins present in the blood. Albumin is the most significant of the plasma proteins in terms 
of drug binding. Some drugs have a high affinity for the binding sites (warfarin is a good 
example) and some a much lower affinity (paracetamol at therapeutic doses) and this affects 
the amount of free drug available for action. Dosing and knowledge of absorption control the 
bioavailability. Affinity is predetermined and cannot be affected by the prescriber. In some 
patients on some medications it is advantageous to know the level of albumin before 
prescribing. Pregnant women, children and some elderly patients can have altered levels of 
plasma proteins. 
Exercise
Using pharmacologically available resources such as textbooks, the BNF or online electronic 
medicines compendium, find the plasma protein binding for a drug from your area of 
practice. 
Duration of Effect
The duration of drug is the period from the time of onset to the time at which sufficient drug 
has been removed from the body to render it as therapeutically ineffective.
This is largely controlled by hepatic metabolism and renal excretion
It is important to know how long a drug will have its effect for. This decides the dosing 
schedules. Drugs need to be given more than once to have continued effect. Some drugs need 
to be given daily, but some need to be given more often to maintain effective drug action. 
This can be deduced from the duration of action of the drug.
Hepatic Metabolism
Enzymes within the microsomes of the liver, including cytochrome P450’s are responsible for
drug metabolism. Anything that affects the function or number of these enzymes can affect 
drug metabolism. These can involve physiological factors, pathological factors, genetics, and 
drug interactions. 
Physiological, Pathological & Genetic
Age, diet, smoking and alcohol intake can all affect hepatic function. In babies and children 
we have an immature liver and must take this reduced metabolic activity into account when 
prescribing. In the elderly we can see reduced liver size and function as a consequence of 
normal ageing.  Chemicals in cigarette smoke can affect the ability of liver enzymes to 
metabolise some drugs, theophylline being the most notable. Excessive alcohol consumption 
can cause liver damage and greatly reduce the function of the organ.
Factors such as liver disease, cirrhosis, and fatty accumulations in the liver can affect the 
ability of the microsomal enzymes.
The main genetic factors that can influence drug metabolism are the presence of 
polymorphisms in the enzymes themselves. These are genetic variations that can change the 
ability of the enzyme to metabolise drugs and affect response, action and duration. 
Common and well documented polymorphisms exist, for example the variant of cytochrome 
P450 known as 2D6 is subject to polymorphism. This enzyme metabolises many drugs 
including some antidepressants.
These factors can reduce live enzyme function and mean that drugs metabolised by the liver 
are done so less efficiently. This can lead to a build-up of the parent drug and may cause side 
effects or toxicity. It will also prolong the level of the drug at or above its therapeutic effect in
the body to an extent which may be undesirable. It is often necessary to reduce doses in liver 
compromise or even avoid certain drugs.
Drug Interactions
Some drugs are inducers or inhibitors of the hepatic microsomal enzyme systems. This means
they can speed up or slow down the metabolism of other drugs and change their therapeutic 
duration of effect. This can prolong or shorten the therapeutic effect of a drug and may have a
clinical significance. Prescribers should be aware of common inducers and inhibitors in their 
area of practice and also check interactions of drugs in the BNF before prescribing if unsure. 
Some common inducer and inhibitors are listed in Box2 but this is not exhaustive.
Box 2
Inducers Inhibitors
Carbamazepine Cimetidine
Rifampicin Erythromycin
St Johns Wort Grapefruit juice
Phenytoin Valproate
Renal Excretion
The kidney excretes drugs and metabolites via the two processes of active glomerular 
filtration and passive tubular secretion. Factors that affect renal function can have an effect on
the ability of the kidneys functional unit, the nephron, to perform these activities. If the 
activity is compromised then excretion of active drug, active and non-active metabolites can 
lead to an increased duration of action, an increase in plasma concentrations of drug 
molecules and potential side effects, adverse effects and toxicity. The extremes of age have 
significant bearing on renal function and should always be considered when prescribing. In 
babies we have an immature renal system and in the elderly the kidneys reduce in size and 
function as a manifestation of ageing therefore excretion of drugs can be compromised. The 
estimation of glomerular filtration rate (eGFR) is a commonly measured feature of renal 
function that can help determine the effectiveness of the kidney. It should be measured in any 
drug which requires extensive renal excretion or in patients where renal compromise is 
suspected. Dosing of drugs in mild, moderate and severe renal failure should be prescribed as
per guidance in the British National Formulary (BNF). 
Exercise
Using pharmacologically available resources such as textbooks, the BNF or online electronic 
medicines compendium, find the prescribing information for a drug from your area of 
practice in patients with hepatic or renal impairment. 
This has been a brief introduction to the concepts of onset and duration of drug action. In 
future articles in this series we will explore aspects of pharmacodynamic actions in more 
detail, looking at first pass metabolism and in more detail at agonists and antagonists.  
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